Ramoril

Administer orally with food or milk to minimize gastrointestinal upset. Swallow the tablet whole with a glass of water.

Ramoril inhibits specific inflammatory mediators and modulates pain pathways in the central nervous system, leading to analgesic and anti-inflammatory effects. It is thought to act via a novel mechanism, distinct from traditional NSAIDs.

• Hypersensitivity to Ramoril or any of its excipients
• Active gastrointestinal bleeding or ulceration
• Severe hepatic impairment
• Severe renal impairment (CrCl <30 mL/min)

Store below 30°C in a dry place, away from direct sunlight and moisture. Keep out of reach of children.

Symptoms may include nausea, vomiting, abdominal pain, drowsiness. Treatment is supportive and symptomatic; gastric lavage or activated charcoal may be considered within an hour of ingestion.

Pregnancy Category C. Use only if potential benefit justifies potential risk to the fetus. Not recommended during breastfeeding as it may be excreted in breast milk.

• Hypersensitivity to Ramoril or any of its excipients
• Active gastrointestinal bleeding or ulceration
• Severe hepatic impairment
• Severe renal impairment (CrCl <30 mL/min)

Store below 30°C in a dry place, away from direct sunlight and moisture. Keep out of reach of children.

Symptoms may include nausea, vomiting, abdominal pain, drowsiness. Treatment is supportive and symptomatic; gastric lavage or activated charcoal may be considered within an hour of ingestion.

Pregnancy Category C. Use only if potential benefit justifies potential risk to the fetus. Not recommended during breastfeeding as it may be excreted in breast milk.